Enteric GFAP expression and phosphorylation in Parkinson's disease
Enteric glial cells (EGCs) are in many respects similar to astrocytes of the central nervous system and express similar proteins including glial fibrillary acidic protein (GFAP). Changes in GFAP expression and/or phosphorylation have been reported during brain damage or central nervous system degene...
Saved in:
| Published in | Journal of neurochemistry Vol. 130; no. 6; pp. 805 - 815 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Blackwell Publishing Ltd
01.09.2014
Wiley |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Enteric glial cells (EGCs) are in many respects similar to astrocytes of the central nervous system and express similar proteins including glial fibrillary acidic protein (GFAP). Changes in GFAP expression and/or phosphorylation have been reported during brain damage or central nervous system degeneration. As in Parkinson's disease (PD) the enteric neurons accumulate α‐synuclein, and thus are showing PD‐specific pathological features, we undertook the present survey to study whether the enteric glia in PD become reactive by assessing the expression and phosphorylation levels of GFAP in colonic biopsies. Twenty‐four PD, six progressive supranuclear palsy (PSP), six multiple system atrophy (MSA) patients, and 21 age‐matched healthy controls were included. The expression levels and the phosphorylation state of GFAP were analyzed in colonic biopsies by western blot. Additional experiments were performed using real‐time PCR for a more precise analysis of the GFAP isoforms expressed by EGCs. We showed that GFAPκ was the main isoform expressed in EGCs. As compared to control subjects, patients with PD, but not PSP and MSA, had significant higher GFAP expression levels in their colonic biopsies. The phosphorylation level of GFAP at serine 13 was significantly lower in PD patients compared to control subjects. By contrast, no change in GFAP phosphorylation was observed between PSP, MSA and controls. Our findings provide evidence that enteric glial reaction occurs in PD and further reinforce the role of the enteric nervous system in the initiation and/or the progression of the disease.
We showed that GFAP is over‐expressed and hypophosphorylated in the enteric glial cells (EGCs) of Parkinson's disease (PD) patients as compared to healthy subjects and patients with atypical parkinsonism (MSA, multiple system atrophy and PSP, progressive supranuclear palsy). Our findings provide evidence that enteric glial reaction occurs in PD but not in PSP and MSA and further reinforce the role of the enteric nervous system in the pathophysiology of PD.
We showed that GFAP is over‐expressed and hypophosphorylated in the enteric glial cells (EGCs) of Parkinson's disease (PD) patients as compared to healthy subjects and patients with atypical parkinsonism (MSA, multiple system atrophy and PSP, progressive supranuclear palsy). Our findings provide evidence that enteric glial reaction occurs in PD but not in PSP and MSA and further reinforce the role of the enteric nervous system in the pathophysiology of PD.
Read the Editorial Highlight for this article on page 729. |
|---|---|
| AbstractList | Enteric glial cells (EGCs) are in many respects similar to astrocytes of the central nervous system and express similar proteins including glial fibrillary acidic protein (GFAP). Changes in GFAP expression and/or phosphorylation have been reported during brain damage or central nervous system degeneration. As in Parkinson's disease (PD) the enteric neurons accumulate α‐synuclein, and thus are showing PD‐specific pathological features, we undertook the present survey to study whether the enteric glia in PD become reactive by assessing the expression and phosphorylation levels of GFAP in colonic biopsies. Twenty‐four PD, six progressive supranuclear palsy (PSP), six multiple system atrophy (MSA) patients, and 21 age‐matched healthy controls were included. The expression levels and the phosphorylation state of GFAP were analyzed in colonic biopsies by western blot. Additional experiments were performed using real‐time PCR for a more precise analysis of the GFAP isoforms expressed by EGCs. We showed that GFAPκ was the main isoform expressed in EGCs. As compared to control subjects, patients with PD, but not PSP and MSA, had significant higher GFAP expression levels in their colonic biopsies. The phosphorylation level of GFAP at serine 13 was significantly lower in PD patients compared to control subjects. By contrast, no change in GFAP phosphorylation was observed between PSP, MSA and controls. Our findings provide evidence that enteric glial reaction occurs in PD and further reinforce the role of the enteric nervous system in the initiation and/or the progression of the disease.
We showed that GFAP is over‐expressed and hypophosphorylated in the enteric glial cells (EGCs) of Parkinson's disease (PD) patients as compared to healthy subjects and patients with atypical parkinsonism (MSA, multiple system atrophy and PSP, progressive supranuclear palsy). Our findings provide evidence that enteric glial reaction occurs in PD but not in PSP and MSA and further reinforce the role of the enteric nervous system in the pathophysiology of PD.
We showed that GFAP is over‐expressed and hypophosphorylated in the enteric glial cells (EGCs) of Parkinson's disease (PD) patients as compared to healthy subjects and patients with atypical parkinsonism (MSA, multiple system atrophy and PSP, progressive supranuclear palsy). Our findings provide evidence that enteric glial reaction occurs in PD but not in PSP and MSA and further reinforce the role of the enteric nervous system in the pathophysiology of PD.
Read the Editorial Highlight for this article on page 729. Enteric glial cells (EGCs) are in many respects similar to astrocytes of the central nervous system and express similar proteins including glial fibrillary acidic protein (GFAP). Changes in GFAP expression and/or phosphorylation have been reported during brain damage or central nervous system degeneration. As in Parkinson's disease (PD) the enteric neurons accumulate α-synuclein, and thus are showing PD-specific pathological features, we undertook the present survey to study whether the enteric glia in PD become reactive by assessing the expression and phosphorylation levels of GFAP in colonic biopsies. Twenty-four PD, six progressive supranuclear palsy (PSP), six multiple system atrophy (MSA) patients, and 21 age-matched healthy controls were included. The expression levels and the phosphorylation state of GFAP were analyzed in colonic biopsies by western blot. Additional experiments were performed using real-time PCR for a more precise analysis of the GFAP isoforms expressed by EGCs. We showed that GFAPκ was the main isoform expressed in EGCs. As compared to control subjects, patients with PD, but not PSP and MSA, had significant higher GFAP expression levels in their colonic biopsies. The phosphorylation level of GFAP at serine 13 was significantly lower in PD patients compared to control subjects. By contrast, no change in GFAP phosphorylation was observed between PSP, MSA and controls. Our findings provide evidence that enteric glial reaction occurs in PD and further reinforce the role of the enteric nervous system in the initiation and/or the progression of the disease. We showed that GFAP is over-expressed and hypophosphorylated in the enteric glial cells (EGCs) of Parkinson's disease (PD) patients as compared to healthy subjects and patients with atypical parkinsonism (MSA, multiple system atrophy and PSP, progressive supranuclear palsy). Our findings provide evidence that enteric glial reaction occurs in PD but not in PSP and MSA and further reinforce the role of the enteric nervous system in the pathophysiology of PD.Enteric glial cells (EGCs) are in many respects similar to astrocytes of the central nervous system and express similar proteins including glial fibrillary acidic protein (GFAP). Changes in GFAP expression and/or phosphorylation have been reported during brain damage or central nervous system degeneration. As in Parkinson's disease (PD) the enteric neurons accumulate α-synuclein, and thus are showing PD-specific pathological features, we undertook the present survey to study whether the enteric glia in PD become reactive by assessing the expression and phosphorylation levels of GFAP in colonic biopsies. Twenty-four PD, six progressive supranuclear palsy (PSP), six multiple system atrophy (MSA) patients, and 21 age-matched healthy controls were included. The expression levels and the phosphorylation state of GFAP were analyzed in colonic biopsies by western blot. Additional experiments were performed using real-time PCR for a more precise analysis of the GFAP isoforms expressed by EGCs. We showed that GFAPκ was the main isoform expressed in EGCs. As compared to control subjects, patients with PD, but not PSP and MSA, had significant higher GFAP expression levels in their colonic biopsies. The phosphorylation level of GFAP at serine 13 was significantly lower in PD patients compared to control subjects. By contrast, no change in GFAP phosphorylation was observed between PSP, MSA and controls. Our findings provide evidence that enteric glial reaction occurs in PD and further reinforce the role of the enteric nervous system in the initiation and/or the progression of the disease. We showed that GFAP is over-expressed and hypophosphorylated in the enteric glial cells (EGCs) of Parkinson's disease (PD) patients as compared to healthy subjects and patients with atypical parkinsonism (MSA, multiple system atrophy and PSP, progressive supranuclear palsy). Our findings provide evidence that enteric glial reaction occurs in PD but not in PSP and MSA and further reinforce the role of the enteric nervous system in the pathophysiology of PD. Enteric glial cells ( EGC s) are in many respects similar to astrocytes of the central nervous system and express similar proteins including glial fibrillary acidic protein ( GFAP ). Changes in GFAP expression and/or phosphorylation have been reported during brain damage or central nervous system degeneration. As in Parkinson's disease ( PD ) the enteric neurons accumulate α‐synuclein, and thus are showing PD ‐specific pathological features, we undertook the present survey to study whether the enteric glia in PD become reactive by assessing the expression and phosphorylation levels of GFAP in colonic biopsies. Twenty‐four PD , six progressive supranuclear palsy ( PSP ), six multiple system atrophy ( MSA ) patients, and 21 age‐matched healthy controls were included. The expression levels and the phosphorylation state of GFAP were analyzed in colonic biopsies by western blot. Additional experiments were performed using real‐time PCR for a more precise analysis of the GFAP isoforms expressed by EGC s. We showed that GFAP κ was the main isoform expressed in EGC s. As compared to control subjects, patients with PD , but not PSP and MSA , had significant higher GFAP expression levels in their colonic biopsies. The phosphorylation level of GFAP at serine 13 was significantly lower in PD patients compared to control subjects. By contrast, no change in GFAP phosphorylation was observed between PSP , MSA and controls. Our findings provide evidence that enteric glial reaction occurs in PD and further reinforce the role of the enteric nervous system in the initiation and/or the progression of the disease. image We showed that GFAP is over‐expressed and hypophosphorylated in the enteric glial cells (EGCs) of Parkinson's disease (PD) patients as compared to healthy subjects and patients with atypical parkinsonism (MSA, multiple system atrophy and PSP, progressive supranuclear palsy). Our findings provide evidence that enteric glial reaction occurs in PD but not in PSP and MSA and further reinforce the role of the enteric nervous system in the pathophysiology of PD. Enteric glial cells ( EGC s) are in many respects similar to astrocytes of the central nervous system and express similar proteins including glial fibrillary acidic protein ( GFAP ). Changes in GFAP expression and/or phosphorylation have been reported during brain damage or central nervous system degeneration. As in Parkinson's disease ( PD ) the enteric neurons accumulate α‐synuclein, and thus are showing PD ‐specific pathological features, we undertook the present survey to study whether the enteric glia in PD become reactive by assessing the expression and phosphorylation levels of GFAP in colonic biopsies. Twenty‐four PD , six progressive supranuclear palsy ( PSP ), six multiple system atrophy ( MSA ) patients, and 21 age‐matched healthy controls were included. The expression levels and the phosphorylation state of GFAP were analyzed in colonic biopsies by western blot. Additional experiments were performed using real‐time PCR for a more precise analysis of the GFAP isoforms expressed by EGC s. We showed that GFAP κ was the main isoform expressed in EGC s. As compared to control subjects, patients with PD , but not PSP and MSA , had significant higher GFAP expression levels in their colonic biopsies. The phosphorylation level of GFAP at serine 13 was significantly lower in PD patients compared to control subjects. By contrast, no change in GFAP phosphorylation was observed between PSP , MSA and controls. Our findings provide evidence that enteric glial reaction occurs in PD and further reinforce the role of the enteric nervous system in the initiation and/or the progression of the disease. image We showed that GFAP is over‐expressed and hypophosphorylated in the enteric glial cells (EGCs) of Parkinson's disease (PD) patients as compared to healthy subjects and patients with atypical parkinsonism (MSA, multiple system atrophy and PSP, progressive supranuclear palsy). Our findings provide evidence that enteric glial reaction occurs in PD but not in PSP and MSA and further reinforce the role of the enteric nervous system in the pathophysiology of PD. Enteric glial cells (EGCs) are in many respects similar to astrocytes of the central nervous system and express similar proteins including glial fibrillary acidic protein (GFAP). Changes in GFAP expression and/or phosphorylation have been reported during brain damage or central nervous system degeneration. As in Parkinson's disease (PD) the enteric neurons accumulate α-synuclein, and thus are showing PD-specific pathological features, we undertook the present survey to study whether the enteric glia in PD become reactive by assessing the expression and phosphorylation levels of GFAP in colonic biopsies. Twenty-four PD, six progressive supranuclear palsy (PSP), six multiple system atrophy (MSA) patients, and 21 age-matched healthy controls were included. The expression levels and the phosphorylation state of GFAP were analyzed in colonic biopsies by western blot. Additional experiments were performed using real-time PCR for a more precise analysis of the GFAP isoforms expressed by EGCs. We showed that GFAPκ was the main isoform expressed in EGCs. As compared to control subjects, patients with PD, but not PSP and MSA, had significant higher GFAP expression levels in their colonic biopsies. The phosphorylation level of GFAP at serine 13 was significantly lower in PD patients compared to control subjects. By contrast, no change in GFAP phosphorylation was observed between PSP, MSA and controls. Our findings provide evidence that enteric glial reaction occurs in PD and further reinforce the role of the enteric nervous system in the initiation and/or the progression of the disease. We showed that GFAP is over-expressed and hypophosphorylated in the enteric glial cells (EGCs) of Parkinson's disease (PD) patients as compared to healthy subjects and patients with atypical parkinsonism (MSA, multiple system atrophy and PSP, progressive supranuclear palsy). Our findings provide evidence that enteric glial reaction occurs in PD but not in PSP and MSA and further reinforce the role of the enteric nervous system in the pathophysiology of PD. Enteric glial cells (EGCs) are in many respects similar to astrocytes of the central nervous system and express similar proteins including glial fibrillary acidic protein (GFAP). Changes in GFAP expression and/or phosphorylation have been reported during brain damage or central nervous system degeneration. As in Parkinson's disease (PD) the enteric neurons accumulate [alpha]-synuclein, and thus are showing PD-specific pathological features, we undertook the present survey to study whether the enteric glia in PD become reactive by assessing the expression and phosphorylation levels of GFAP in colonic biopsies. Twenty-four PD, six progressive supranuclear palsy (PSP), six multiple system atrophy (MSA) patients, and 21 age-matched healthy controls were included. The expression levels and the phosphorylation state of GFAP were analyzed in colonic biopsies by western blot. Additional experiments were performed using real-time PCR for a more precise analysis of the GFAP isoforms expressed by EGCs. We showed that GFAP[kappa] was the main isoform expressed in EGCs. As compared to control subjects, patients with PD, but not PSP and MSA, had significant higher GFAP expression levels in their colonic biopsies. The phosphorylation level of GFAP at serine 13 was significantly lower in PD patients compared to control subjects. By contrast, no change in GFAP phosphorylation was observed between PSP,MSA and controls. Our findings provide evidence that enteric glial reaction occurs in PD and further reinforce the role of the enteric nervous system in the initiation and/or the progression of the disease. We showed that GFAP is over-expressed and hypophosphorylated in the enteric glial cells (EGCs) of Parkinson's disease (PD) patients as compared to healthy subjects and patients with atypical parkinsonism (MSA, multiple system atrophy and PSP, progressive supranuclear palsy). Our findings provide evidence that enteric glial reaction occurs in PD but not in PSP and MSA and further reinforce the role of the enteric nervous system in the pathophysiology of PD. [PUBLICATION ABSTRACT] Enteric glial cells (EGCs) are in many respects similar to astrocytes of the central nervous system and express similar proteins including glial fibrillary acidic protein (GFAP). Changes in GFAP expression and/or phosphorylation have been reported during brain damage or central nervous system degeneration. As in Parkinson's disease (PD) the enteric neurons accumulate alpha -synuclein, and thus are showing PD-specific pathological features, we undertook the present survey to study whether the enteric glia in PD become reactive by assessing the expression and phosphorylation levels of GFAP in colonic biopsies. Twenty-four PD, six progressive supranuclear palsy (PSP), six multiple system atrophy (MSA) patients, and 21 age-matched healthy controls were included. The expression levels and the phosphorylation state of GFAP were analyzed in colonic biopsies by western blot. Additional experiments were performed using real-time PCR for a more precise analysis of the GFAP isoforms expressed by EGCs. We showed that GFAP Kappa was the main isoform expressed in EGCs. As compared to control subjects, patients with PD, but not PSP and MSA, had significant higher GFAP expression levels in their colonic biopsies. The phosphorylation level of GFAP at serine 13 was significantly lower in PD patients compared to control subjects. By contrast, no change in GFAP phosphorylation was observed between PSP, MSA and controls. Our findings provide evidence that enteric glial reaction occurs in PD and further reinforce the role of the enteric nervous system in the initiation and/or the progression of the disease. We showed that GFAP is over-expressed and hypophosphorylated in the enteric glial cells (EGCs) of Parkinson's disease (PD) patients as compared to healthy subjects and patients with atypical parkinsonism (MSA, multiple system atrophy and PSP, progressive supranuclear palsy). Our findings provide evidence that enteric glial reaction occurs in PD but not in PSP and MSA and further reinforce the role of the enteric nervous system in the pathophysiology of PD. We showed that GFAP is over-expressed and hypophosphorylated in the enteric glial cells (EGCs) of Parkinson's disease (PD) patients as compared to healthy subjects and patients with atypical parkinsonism (MSA, multiple system atrophy and PSP, progressive supranuclear palsy). Our findings provide evidence that enteric glial reaction occurs in PD but not in PSP and MSA and further reinforce the role of the enteric nervous system in the pathophysiology of PD. Read the Editorial Highlight for this article on page 729. |
| Author | Clairembault, Thomas Rolli‐Derkinderen, Malvyne Hol, Elly M. Kamphuis, Willem Leclair‐Visonneau, Laurène Neunlist, Michel Derkinderen, Pascal Coron, Emmanuel |
| Author_xml | – sequence: 1 givenname: Thomas surname: Clairembault fullname: Clairembault, Thomas organization: Institut des Maladies de l'Appareil Digestif – sequence: 2 givenname: Willem surname: Kamphuis fullname: Kamphuis, Willem organization: an institute of the Royal Netherlands Academy of Arts and Sciences – sequence: 3 givenname: Laurène surname: Leclair‐Visonneau fullname: Leclair‐Visonneau, Laurène organization: University Nantes – sequence: 4 givenname: Malvyne surname: Rolli‐Derkinderen fullname: Rolli‐Derkinderen, Malvyne organization: University Nantes – sequence: 5 givenname: Emmanuel surname: Coron fullname: Coron, Emmanuel organization: Institut des Maladies de l'Appareil Digestif – sequence: 6 givenname: Michel surname: Neunlist fullname: Neunlist, Michel organization: Institut des Maladies de l'Appareil Digestif – sequence: 7 givenname: Elly M. orcidid: 0000-0001-5604-2603 surname: Hol fullname: Hol, Elly M. organization: University Medical Center Utrecht – sequence: 8 givenname: Pascal surname: Derkinderen fullname: Derkinderen, Pascal organization: University Nantes |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24749759$$D View this record in MEDLINE/PubMed https://hal.science/hal-04875764$$DView record in HAL |
| BookMark | eNqNkU1PGzEQhi1EBSHtgT-AVuJAOSz42-tjiPhoFVEO7dnyOrPCYWMHewPk33dDgEpIRYxmNNLomdHMvHtoO8QACO0TfEJ6O50Fd0Ko4nQLDQhXpORE6G00wJjSkmFOd9FezjOMieSS7KBdyhXXSugBOjsPHSTvisuL0U0BT4sEOfsYChumxeI25j7SqrXduuZDcWPTnQ85hqNcTH0Gm-Er-tLYNsO3lzxEfy7Of4-vysmvyx_j0aR0gmhaWsV4XTVV1ThJJa04rzWfNhSoBGBSY-wUkIYoKYQGzZzVTDSKaCukq2vChuh4M_fWtmaR_NymlYnWm6vRxKxrmFdKKMkf1uz3DbtI8X4JuTNznx20rQ0Ql9kQIWXFNMWfQrFQivU-RIfv0FlcptAf3VNCc64loz118EIt6zlM31Z9ffq_Q1yKOSdo3hCCzVpQ0wtqngXt2dN3rPPdsxpdsr79qOPRt7D6_2jz83q86fgLh3utOw |
| CitedBy_id | crossref_primary_10_1111_dgd_12826 crossref_primary_10_1111_jcmm_70099 crossref_primary_10_3390_cells11050832 crossref_primary_10_1016_j_semcdb_2023_01_005 crossref_primary_10_1177_0960327117751236 crossref_primary_10_3390_molecules27196773 crossref_primary_10_3748_wjg_v21_i37_10609 crossref_primary_10_3233_JPD_230206 crossref_primary_10_3389_fnins_2018_00612 crossref_primary_10_1016_j_isci_2021_102863 crossref_primary_10_1007_s11064_020_03210_z crossref_primary_10_3389_fimmu_2024_1302488 crossref_primary_10_3389_fnagi_2017_00057 crossref_primary_10_1177_17590914221102065 crossref_primary_10_1016_j_bbi_2017_06_018 crossref_primary_10_3233_JPD_181477 crossref_primary_10_3390_nu11040753 crossref_primary_10_1007_s00401_017_1777_8 crossref_primary_10_1021_acs_iecr_2c01445 crossref_primary_10_1007_s00401_021_02381_5 crossref_primary_10_1007_s11011_018_0239_x crossref_primary_10_1111_nmo_12933 crossref_primary_10_1111_bph_16226 crossref_primary_10_3233_JPD_223294 crossref_primary_10_3389_fneur_2018_00954 crossref_primary_10_58920_sciphy01010047 crossref_primary_10_1016_j_neurobiolaging_2023_05_007 crossref_primary_10_1177_1759091415601636 crossref_primary_10_1021_acssensors_1c02232 crossref_primary_10_3390_ijms241512475 crossref_primary_10_3390_pharmaceutics14071354 crossref_primary_10_3389_fneur_2019_01155 crossref_primary_10_1002_mds_29358 crossref_primary_10_1007_s00702_021_02445_6 crossref_primary_10_3892_mmr_2017_6471 crossref_primary_10_1016_j_pneurobio_2018_11_003 crossref_primary_10_1177_1759091420981206 crossref_primary_10_1053_j_gastro_2014_09_040 crossref_primary_10_3389_fnins_2023_1281710 crossref_primary_10_1038_cddis_2017_517 crossref_primary_10_1111_ejn_15892 crossref_primary_10_31857_S0869813924090015 crossref_primary_10_1111_nmo_12797 crossref_primary_10_1016_j_nbd_2019_104581 crossref_primary_10_3390_jcm12165231 crossref_primary_10_1016_j_parkreldis_2018_11_014 crossref_primary_10_3390_molecules23040814 crossref_primary_10_3390_ijms25021294 crossref_primary_10_3389_fnagi_2020_00126 crossref_primary_10_1016_j_parkreldis_2016_03_012 crossref_primary_10_1002_glia_22795 crossref_primary_10_3390_ijms25021037 crossref_primary_10_1111_ene_15607 crossref_primary_10_1093_jnen_nlx092 crossref_primary_10_1007_s10571_021_01066_7 crossref_primary_10_2147_IDR_S342782 crossref_primary_10_1101_cshperspect_a021642 crossref_primary_10_1007_s12031_024_02254_y crossref_primary_10_1007_s12035_023_03679_z crossref_primary_10_1016_j_brainres_2021_147442 crossref_primary_10_1146_annurev_immunol_042718_041812 crossref_primary_10_1152_ajpgi_00016_2018 crossref_primary_10_4103_1673_5374_276323 crossref_primary_10_3390_ijms23179739 crossref_primary_10_3390_ijms21239199 crossref_primary_10_1096_fj_202100087R crossref_primary_10_1002_mds_25979 crossref_primary_10_1002_mds_29937 crossref_primary_10_1038_s41575_021_00423_7 crossref_primary_10_21518_2079_701X_2019_18_61_70 crossref_primary_10_1002_mds_27237 crossref_primary_10_1016_j_brainres_2021_147609 crossref_primary_10_3389_fphar_2024_1403767 crossref_primary_10_1038_nrneurol_2015_197 crossref_primary_10_1016_j_tins_2015_04_003 crossref_primary_10_14802_jmd_18067 crossref_primary_10_1177_1721727X221083763 crossref_primary_10_1080_07315724_2020_1852981 crossref_primary_10_1016_j_apsb_2025_02_029 crossref_primary_10_1080_17512433_2019_1612744 crossref_primary_10_3389_fphar_2020_00158 crossref_primary_10_37349_en_2024_00042 crossref_primary_10_3390_cells13100799 crossref_primary_10_1172_JCI76303 crossref_primary_10_1097_MIB_0000000000000667 crossref_primary_10_1007_s00221_020_05868_x crossref_primary_10_1111_acel_12941 crossref_primary_10_1016_j_lfs_2022_120494 crossref_primary_10_1038_s41598_020_78340_z crossref_primary_10_1016_j_lfs_2024_122793 crossref_primary_10_3389_fnins_2022_905722 crossref_primary_10_14336_AD_2022_01281 crossref_primary_10_1186_s12916_023_03120_1 crossref_primary_10_3748_wjg_v26_i14_1564 crossref_primary_10_52965_001c_36074 crossref_primary_10_1134_S0022093024050090 crossref_primary_10_1177_10738584231163460 crossref_primary_10_3389_fnins_2019_00905 crossref_primary_10_1111_jnc_14656 crossref_primary_10_23934_2223_9022_2023_12_4_625_636 crossref_primary_10_1007_s12031_022_02044_4 crossref_primary_10_3390_molecules26123762 crossref_primary_10_1093_brain_awac261 crossref_primary_10_1016_j_brainresbull_2022_06_013 crossref_primary_10_1016_j_neurol_2023_11_004 crossref_primary_10_3390_ijms25115726 crossref_primary_10_1007_s11062_016_9568_8 crossref_primary_10_3389_fnmol_2020_00157 crossref_primary_10_1016_j_jaci_2022_07_015 crossref_primary_10_3389_fnagi_2022_810483 crossref_primary_10_3390_life11080732 crossref_primary_10_1002_ar_24128 crossref_primary_10_3389_fimmu_2021_718220 crossref_primary_10_3390_microorganisms5040066 crossref_primary_10_1186_s40478_018_0568_3 crossref_primary_10_3233_JPD_223568 crossref_primary_10_1212_WNL_0000000000005534 crossref_primary_10_12677_acm_2024_14123217 crossref_primary_10_1053_j_gastro_2016_07_044 crossref_primary_10_1038_s41582_022_00681_2 crossref_primary_10_1177_1759091420949680 crossref_primary_10_1002_glia_22876 crossref_primary_10_1038_s41531_023_00458_4 crossref_primary_10_1038_s41598_024_65061_w crossref_primary_10_3389_fnagi_2020_599045 crossref_primary_10_1096_fj_201900916R crossref_primary_10_1038_srep24868 crossref_primary_10_1155_2018_3464578 crossref_primary_10_1016_j_nbd_2023_106296 crossref_primary_10_1038_s41582_021_00616_3 crossref_primary_10_1093_nutrit_nuab024 crossref_primary_10_1111_nmo_13726 crossref_primary_10_1007_s00401_018_1856_5 crossref_primary_10_1152_ajpgi_00225_2023 crossref_primary_10_1186_s40478_015_0196_0 crossref_primary_10_3389_fimmu_2024_1394654 crossref_primary_10_1111_1440_1681_13563 crossref_primary_10_1093_brain_awab156 crossref_primary_10_3389_fneur_2024_1375971 |
| Cites_doi | 10.1002/glia.10169 10.1523/JNEUROSCI.22-16-06972.2002 10.1016/j.neurobiolaging.2013.09.035 10.4137/BMI.S9873 10.1096/fj.09-139519 10.1136/gut.2003.012625 10.1007/s00401-010-0664-3 10.1016/S0092-8674(00)81571-8 10.1016/j.nbd.2005.05.021 10.1212/01.wnl.0000324625.00404.15 10.1016/j.jneumeth.2008.11.003 10.1002/glia.20243 10.1002/mds.870080115 10.1021/pr100666c 10.1073/pnas.231474098 10.1016/0306-4522(93)90175-F 10.1515/JBCPP.1993.4.3.157 10.1111/j.1365-2982.2005.00687.x 10.1152/ajpgi.2001.280.6.G1163 10.1016/S0006-8993(00)02180-6 10.3389/fncel.2013.00183 10.1038/sj.mp.4001379 10.1111/j.1440-1789.2011.01268.x 10.1016/j.pneurobio.2011.01.005 10.1111/j.1750-3639.1994.tb00839.x 10.1002/glia.20475 10.1002/mds.22051 10.1097/NEN.0b013e3181b66f1b 10.1016/j.neulet.2005.11.012 10.1523/JNEUROSCI.03-11-02206.1983 10.1212/WNL.46.4.922 10.1016/j.parkreldis.2012.04.020 10.1152/ajpgi.2000.278.4.G644 10.1212/01.wnl.0000312279.49272.9f 10.1111/j.1365-2982.2009.01368.x 10.1007/s12035-012-8267-8 10.3389/fpsyt.2010.00128 10.1136/gut.2005.067595 10.1038/nrgastro.2012.138 10.1093/brain/awf080 10.1111/j.1582-4934.2009.00686.x 10.1038/286736a0 10.1212/WNL.0b013e318236ef60 10.1371/journal.pone.0012728 10.1038/nrgastro.2012.221 10.1002/(SICI)1097-4547(19990501)56:3<219::AID-JNR1>3.0.CO;2-2 10.1097/MOG.0b013e3283572ffa 10.1186/1471-230X-11-3 10.1016/j.nbd.2012.09.007 10.1371/journal.pone.0042823 10.1152/ajpgi.00427.2010 10.1007/s00401-010-0706-x 10.1007/s11064-012-0774-5 10.1016/0169-328X(95)00010-P |
| ContentType | Journal Article |
| Copyright | 2014 International Society for Neurochemistry 2014 International Society for Neurochemistry. Copyright © 2014 International Society for Neurochemistry Copyright |
| Copyright_xml | – notice: 2014 International Society for Neurochemistry – notice: 2014 International Society for Neurochemistry. – notice: Copyright © 2014 International Society for Neurochemistry – notice: Copyright |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7X8 1XC |
| DOI | 10.1111/jnc.12742 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Chemoreception Abstracts Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic Hyper Article en Ligne (HAL) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE Virology and AIDS Abstracts Neurosciences Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry |
| EISSN | 1471-4159 |
| EndPage | 815 |
| ExternalDocumentID | oai_HAL_hal_04875764v1 3421286871 24749759 10_1111_jnc_12742 JNC12742 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Michael J. Fox Foundation for Parkinson's Research – fundername: centre d'entraide et de coordination des associations de parkinsoniens – fundername: PSP France |
| GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29L 2WC 31~ 33P 36B 3SF 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAYJJ AAZKR ABCQN ABCUV ABEML ABIVO ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOD ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FZ0 G-S G.N GAKWD GODZA GX1 H.X HF~ HGLYW HH5 HVGLF HZI HZ~ IH2 IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TWZ UB1 V8K VH1 W8V W99 WBKPD WIH WIJ WIK WIN WNSPC WOHZO WOW WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XJT YFH YNH YOC YUY ZGI ZXP ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 7U9 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY C1K FR3 H94 P64 7X8 1XC |
| ID | FETCH-LOGICAL-c5192-a734b8f88fc6262844b94df2e26ee36900c7e1f176559e93ca935f719a56cbb13 |
| IEDL.DBID | DR2 |
| ISSN | 0022-3042 1471-4159 |
| IngestDate | Sat Jul 12 03:12:43 EDT 2025 Thu Jul 10 22:21:44 EDT 2025 Fri Jul 11 01:39:08 EDT 2025 Sat Aug 16 22:22:53 EDT 2025 Thu Apr 03 07:08:46 EDT 2025 Thu Apr 24 23:00:05 EDT 2025 Tue Jul 01 04:39:01 EDT 2025 Wed Jan 22 16:54:59 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | enteric glial cells Parkinson's disease enteric nervous system multiple system atrophy glial fibrillary acidic protein progressive supranuclear palsy |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2014 International Society for Neurochemistry. Copyright: http://hal.archives-ouvertes.fr/licences/copyright |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5192-a734b8f88fc6262844b94df2e26ee36900c7e1f176559e93ca935f719a56cbb13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-5604-2603 0000-0001-6379-0765 0000-0001-8792-2582 |
| PMID | 24749759 |
| PQID | 1559449632 |
| PQPubID | 31528 |
| PageCount | 11 |
| ParticipantIDs | hal_primary_oai_HAL_hal_04875764v1 proquest_miscellaneous_1566839201 proquest_miscellaneous_1560577377 proquest_journals_1559449632 pubmed_primary_24749759 crossref_primary_10_1111_jnc_12742 crossref_citationtrail_10_1111_jnc_12742 wiley_primary_10_1111_jnc_12742_JNC12742 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | September 2014 |
| PublicationDateYYYYMMDD | 2014-09-01 |
| PublicationDate_xml | – month: 09 year: 2014 text: September 2014 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: New York |
| PublicationTitle | Journal of neurochemistry |
| PublicationTitleAlternate | J Neurochem |
| PublicationYear | 2014 |
| Publisher | Blackwell Publishing Ltd Wiley |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley |
| References | 1993; 8 1995; 30 1983; 3 2011; 11 2005; 20 2012; 18 2013; 7 2009; 119 2008; 70 2008; 71 1993; 4 2009; 13 2010; 24 2013; 10 2013; 50 2003; 8 1999; 56 2008; 23 2010c; 1 2012; 28 1998; 93 2008; 64 2003; 41 2010; 9 2001; 98 2009; 68 2013; 47 2000; 278 2006; 55 2001; 280 2006; 396 2011; 77 2009; 178 2010; 120 2012; 37 2007; 55 2012; 32 2010b; 5 2004; 53 2011; 300 2010a; 22 2000; 864 2011; 93 2002; 125 1993; 52 2002; 22 2005; 52 2014; 35 2012; 7 1996; 46 2005; 17 1980; 286 1994; 4 2012; 9 e_1_2_7_5_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_17_1 e_1_2_7_15_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_49_1 e_1_2_7_28_1 e_1_2_7_50_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_52_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_54_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_56_1 e_1_2_7_37_1 e_1_2_7_39_1 e_1_2_7_6_1 e_1_2_7_4_1 e_1_2_7_8_1 e_1_2_7_18_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_48_1 e_1_2_7_27_1 e_1_2_7_29_1 Jessen K. R. (e_1_2_7_30_1) 1983; 3 Marek K. (e_1_2_7_41_1) 2008; 64 e_1_2_7_51_1 e_1_2_7_53_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_55_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_38_1 24909200 - J Neurochem. 2014 Sep;130(6):729-32 |
| References_xml | – volume: 11 start-page: 3 year: 2011 article-title: Distribution of enteric glia and GDNF during gut inflammation publication-title: BMC Gastroenterol. – volume: 53 start-page: 222 year: 2004 end-page: 228 article-title: Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia publication-title: Gut – volume: 98 start-page: 13306 year: 2001 end-page: 13311 article-title: Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease? publication-title: Proc. Natl Acad. Sci. USA – volume: 10 start-page: 90 year: 2013 end-page: 100 article-title: The digestive neuronal‐glial‐epithelial unit: a new actor in gut health and disease publication-title: Nat. Rev. Gastroenterol. Hepatol. – volume: 7 start-page: e42823 year: 2012 article-title: GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease publication-title: PLoS ONE – volume: 5 start-page: e12728 year: 2010b article-title: Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms publication-title: PLoS ONE – volume: 7 start-page: 183 year: 2013 article-title: Imaging neuron‐glia interactions in the enteric nervous system publication-title: Front. Cell. Neurosci. – volume: 22 start-page: e11 year: 2010a end-page: 4 article-title: Routine colonic biopsies as a new tool to study the enteric nervous system in living patients publication-title: Neurogastroenterol. Motil. – volume: 71 start-page: 670 year: 2008 end-page: 676 article-title: Second consensus statement on the diagnosis of multiple system atrophy publication-title: Neurology – volume: 37 start-page: 2364 year: 2012 end-page: 2378 article-title: Phosphorylation of GFAP is associated with injury in the neonatal pig hypoxic‐ischemic brain publication-title: Neurochem. Res. – volume: 864 start-page: 220 year: 2000 end-page: 229 article-title: Rapid increase in immunoreactivity to GFAP in astrocytes in vitro induced by acidic pH is mediated by calcium influx and calpain I publication-title: Brain Res. – volume: 28 start-page: 557 year: 2012 end-page: 562 article-title: On communication between gut microbes and the brain publication-title: Curr. Opin. Gastroenterol. – volume: 47 start-page: 561 year: 2013 end-page: 574 article-title: Inflammation and α‐synuclein”s prion‐like behavior in Parkinson”s disease–is there a link? publication-title: Mol. Neurobiol. – volume: 46 start-page: 922 year: 1996 end-page: 930 article-title: Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele‐Richardson‐Olszewski syndrome) publication-title: Neurology – volume: 286 start-page: 736 year: 1980 end-page: 737 article-title: Glial cells in the enteric nervous system contain glial fibrillary acidic protein publication-title: Nature – volume: 56 start-page: 219 year: 1999 end-page: 228 article-title: Structural features of the rat GFAP gene and identification of a novel alternative transcript publication-title: J. Neurosci. Res. – volume: 17 start-page: 777 year: 2005 end-page: 790 article-title: Glial cells in the gut publication-title: Neurogastroenterol. Motil. – volume: 55 start-page: 497 year: 2007 end-page: 507 article-title: Identification and characterization of GFAPkappa, a novel glial fibrillary acidic protein isoform publication-title: Glia – volume: 125 start-page: 861 year: 2002 end-page: 870 article-title: The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service publication-title: Brain – volume: 178 start-page: 1 year: 2009 end-page: 9 article-title: Versatile, high‐resolution anterograde labeling of vagal efferent projections with dextran amines publication-title: J. Neurosci. Methods – volume: 300 start-page: G976 year: 2011 end-page: G987 article-title: Enteric glia promote intestinal mucosal healing via activation of focal adhesion kinase and release of proEGF publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. – volume: 280 start-page: G1163 year: 2001 end-page: G1171 article-title: Interleukin‐6 expression and regulation in rat enteric glial cells publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. – volume: 4 start-page: 157 year: 1993 end-page: 179 article-title: Neurons and glial cells of the enteric nervous system: studies in tissue culture publication-title: J. Basic Clin. Physiol. Pharmacol. – volume: 23 start-page: 1065 year: 2008 end-page: 1075 article-title: Neural control of the gastrointestinal tract: implications for Parkinson disease publication-title: Mov. Disord. – volume: 8 start-page: 83 year: 1993 end-page: 86 article-title: Gastrointestinal symptoms in Parkinson disease: 18‐month follow‐up study publication-title: Mov. Disord. – volume: 120 start-page: 1 year: 2010 end-page: 12 article-title: Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain publication-title: Acta Neuropathol. – volume: 32 start-page: 440 year: 2012 end-page: 446 article-title: Clinical aspects and pathology of Alexander disease, and morphological and functional alteration of astrocytes induced by GFAP mutation publication-title: Neuropathology – volume: 30 start-page: 251 year: 1995 end-page: 258 article-title: A novel glial fibrillary acidic protein mRNA lacking exon 1 publication-title: Brain Res. – volume: 4 start-page: 239 year: 1994 end-page: 243 article-title: Glial fibrillary acidic protein: dynamic property and regulation by phosphorylation publication-title: Brain Pathol. – volume: 9 start-page: 6368 year: 2010 end-page: 6379 article-title: Phosphoproteomic analysis reveals site‐specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration publication-title: J. Proteome Res. – volume: 20 start-page: 858 year: 2005 end-page: 870 article-title: Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain publication-title: Neurobiol. Dis. – volume: 7 start-page: 71 year: 2012 end-page: 79 article-title: Characterization of antibodies that detect human GFAP after traumatic brain injury publication-title: Biomark. Insights – volume: 50 start-page: 42 year: 2013 end-page: 48 article-title: Colonic inflammation in Parkinson's disease publication-title: Neurobiol. Dis. – volume: 70 start-page: 1916 year: 2008 end-page: 1925 article-title: Invited article: nervous system pathology in sporadic Parkinson disease publication-title: Neurology – volume: 93 start-page: 189 year: 1998 end-page: 201 article-title: Fulminant jejuno‐ileitis following ablation of enteric glia in adult transgenic mice publication-title: Cell – volume: 8 start-page: 786 year: 2003 end-page: 796 article-title: Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms publication-title: Mol. Psychiatry – volume: 22 start-page: 6972 year: 2002 end-page: 6979 article-title: Protective role of phosphorylation in turnover of glial fibrillary acidic protein in mice publication-title: J. Neurosci. – volume: 9 start-page: 625 year: 2012 end-page: 632 article-title: Novel functional roles for enteric glia in the gastrointestinal tract publication-title: Nat. Rev. Gastroenterol. Hepatol. – volume: 68 start-page: 1073 year: 2009 end-page: 1083 article-title: Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression publication-title: J. Neuropathol. Exp. Neurol. – volume: 18 start-page: 893 year: 2012 end-page: 895 article-title: Analysis of colonic alpha‐synuclein pathology in multiple system atrophy publication-title: Parkinsonism Relat. Disord. – volume: 119 start-page: 689 year: 2009 end-page: 702 article-title: Multi‐organ distribution of phosphorylated alpha‐synuclein histopathology in subjects with Lewy body disorders publication-title: Acta Neuropathol. – volume: 41 start-page: 81 year: 2003 end-page: 93 article-title: Role of enteric glial cells in inflammatory bowel disease publication-title: Glia – volume: 3 start-page: 2206 year: 1983 end-page: 2218 article-title: Astrocyte‐like glia in the peripheral nervous system: an immunohistochemical study of enteric glia publication-title: J. Neurosci. – volume: 278 start-page: G644 year: 2000 end-page: G651 article-title: Patch‐clamp study of neurons and glial cells in isolated myenteric ganglia publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. – volume: 13 start-page: 2261 year: 2009 end-page: 2270 article-title: Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium‐dependent potassium channel opening publication-title: J. Cell Mol. Med. – volume: 396 start-page: 67 year: 2006 end-page: 72 article-title: Gastric alpha‐synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease‐related brain pathology publication-title: Neurosci. Lett. – volume: 24 start-page: 1082 year: 2010 end-page: 1094 article-title: Enteric glial cells protect neurons from oxidative stress in part via reduced glutathione publication-title: FASEB J. – volume: 1 start-page: 128 year: 2010c article-title: Biopsable neural tissues: toward new biomarkers for Parkinson's disease? publication-title: Front. Psychiatry – volume: 55 start-page: 630 year: 2006 end-page: 637 article-title: Changes in enteric neurone phenotype and intestinal functions in a transgenic mouse model of enteric glia disruption publication-title: Gut – volume: 64 start-page: S111 issue: Suppl 2 year: 2008 end-page: S121 article-title: Biomarkers for Parkinson”s [corrected] disease: tools to assess Parkinson”s disease onset and progression publication-title: Ann. Neurol. – volume: 93 start-page: 421 year: 2011 end-page: 443 article-title: GFAP in health and disease publication-title: Prog. Neurobiol. – volume: 35 start-page: 492 year: 2014 end-page: 510 article-title: Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease publication-title: Neurobiol. Aging – volume: 52 start-page: 1 year: 1993 end-page: 6 article-title: Glutathione peroxidase, glial cells and Parkinson's disease publication-title: Neuroscience – volume: 77 start-page: 1761 year: 2011 end-page: 1767 article-title: Parkinson disease: the enteric nervous system spills its guts publication-title: Neurology – volume: 52 start-page: 289 year: 2005 end-page: 300 article-title: Adult human subventricular, subgranular, and subpial zones contain astrocytes with a specialized intermediate filament cytoskeleton publication-title: Glia – ident: e_1_2_7_12_1 doi: 10.1002/glia.10169 – ident: e_1_2_7_50_1 doi: 10.1523/JNEUROSCI.22-16-06972.2002 – ident: e_1_2_7_32_1 doi: 10.1016/j.neurobiolaging.2013.09.035 – ident: e_1_2_7_56_1 doi: 10.4137/BMI.S9873 – ident: e_1_2_7_2_1 doi: 10.1096/fj.09-139519 – ident: e_1_2_7_7_1 doi: 10.1136/gut.2003.012625 – ident: e_1_2_7_4_1 doi: 10.1007/s00401-010-0664-3 – ident: e_1_2_7_11_1 doi: 10.1016/S0092-8674(00)81571-8 – ident: e_1_2_7_33_1 doi: 10.1016/j.nbd.2005.05.021 – ident: e_1_2_7_21_1 doi: 10.1212/01.wnl.0000324625.00404.15 – ident: e_1_2_7_53_1 doi: 10.1016/j.jneumeth.2008.11.003 – ident: e_1_2_7_45_1 doi: 10.1002/glia.20243 – ident: e_1_2_7_19_1 doi: 10.1002/mds.870080115 – ident: e_1_2_7_25_1 doi: 10.1021/pr100666c – ident: e_1_2_7_15_1 doi: 10.1073/pnas.231474098 – ident: e_1_2_7_16_1 doi: 10.1016/0306-4522(93)90175-F – ident: e_1_2_7_23_1 doi: 10.1515/JBCPP.1993.4.3.157 – ident: e_1_2_7_46_1 doi: 10.1111/j.1365-2982.2005.00687.x – ident: e_1_2_7_47_1 doi: 10.1152/ajpgi.2001.280.6.G1163 – ident: e_1_2_7_38_1 doi: 10.1016/S0006-8993(00)02180-6 – ident: e_1_2_7_6_1 doi: 10.3389/fncel.2013.00183 – ident: e_1_2_7_26_1 doi: 10.1038/sj.mp.4001379 – ident: e_1_2_7_54_1 doi: 10.1111/j.1440-1789.2011.01268.x – ident: e_1_2_7_42_1 doi: 10.1016/j.pneurobio.2011.01.005 – ident: e_1_2_7_28_1 doi: 10.1111/j.1750-3639.1994.tb00839.x – ident: e_1_2_7_5_1 doi: 10.1002/glia.20475 – ident: e_1_2_7_13_1 doi: 10.1002/mds.22051 – ident: e_1_2_7_48_1 doi: 10.1097/NEN.0b013e3181b66f1b – volume: 64 start-page: S111 issue: 2 year: 2008 ident: e_1_2_7_41_1 article-title: Biomarkers for Parkinson”s [corrected] disease: tools to assess Parkinson”s disease onset and progression publication-title: Ann. Neurol. – ident: e_1_2_7_10_1 doi: 10.1016/j.neulet.2005.11.012 – volume: 3 start-page: 2206 year: 1983 ident: e_1_2_7_30_1 article-title: Astrocyte‐like glia in the peripheral nervous system: an immunohistochemical study of enteric glia publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.03-11-02206.1983 – ident: e_1_2_7_40_1 doi: 10.1212/WNL.46.4.922 – ident: e_1_2_7_44_1 doi: 10.1016/j.parkreldis.2012.04.020 – ident: e_1_2_7_24_1 doi: 10.1152/ajpgi.2000.278.4.G644 – ident: e_1_2_7_9_1 doi: 10.1212/01.wnl.0000312279.49272.9f – ident: e_1_2_7_35_1 doi: 10.1111/j.1365-2982.2009.01368.x – ident: e_1_2_7_39_1 doi: 10.1007/s12035-012-8267-8 – ident: e_1_2_7_37_1 doi: 10.3389/fpsyt.2010.00128 – ident: e_1_2_7_3_1 doi: 10.1136/gut.2005.067595 – ident: e_1_2_7_22_1 doi: 10.1038/nrgastro.2012.138 – ident: e_1_2_7_27_1 doi: 10.1093/brain/awf080 – ident: e_1_2_7_34_1 doi: 10.1111/j.1582-4934.2009.00686.x – ident: e_1_2_7_29_1 doi: 10.1038/286736a0 – ident: e_1_2_7_17_1 doi: 10.1212/WNL.0b013e318236ef60 – ident: e_1_2_7_36_1 doi: 10.1371/journal.pone.0012728 – ident: e_1_2_7_43_1 doi: 10.1038/nrgastro.2012.221 – ident: e_1_2_7_14_1 doi: 10.1002/(SICI)1097-4547(19990501)56:3<219::AID-JNR1>3.0.CO;2-2 – ident: e_1_2_7_20_1 doi: 10.1097/MOG.0b013e3283572ffa – ident: e_1_2_7_8_1 doi: 10.1186/1471-230X-11-3 – ident: e_1_2_7_18_1 doi: 10.1016/j.nbd.2012.09.007 – ident: e_1_2_7_31_1 doi: 10.1371/journal.pone.0042823 – ident: e_1_2_7_51_1 doi: 10.1152/ajpgi.00427.2010 – ident: e_1_2_7_52_1 doi: 10.1007/s00401-010-0706-x – ident: e_1_2_7_49_1 doi: 10.1007/s11064-012-0774-5 – ident: e_1_2_7_55_1 doi: 10.1016/0169-328X(95)00010-P – reference: 24909200 - J Neurochem. 2014 Sep;130(6):729-32 |
| SSID | ssj0016461 |
| Score | 2.5113666 |
| Snippet | Enteric glial cells (EGCs) are in many respects similar to astrocytes of the central nervous system and express similar proteins including glial fibrillary... Enteric glial cells ( EGC s) are in many respects similar to astrocytes of the central nervous system and express similar proteins including glial fibrillary... Enteric glial cells ( EGC s) are in many respects similar to astrocytes of the central nervous system and express similar proteins including glial fibrillary... |
| SourceID | hal proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 805 |
| SubjectTerms | Adult Aged Amino Acid Sequence Animals Biopsy Blotting, Western Brain Chemistry Brain Chemistry - drug effects Cell Line Colon Colon - metabolism enteric glial cells enteric nervous system Female Glial Fibrillary Acidic Protein Glial Fibrillary Acidic Protein - biosynthesis Glial Fibrillary Acidic Protein - metabolism Human health and pathology Humans Life Sciences Male Middle Aged Molecular Sequence Data multiple system atrophy Nervous system Neuroglia Neuroglia - metabolism Parkinson Disease Parkinson Disease - metabolism Parkinson's disease Phosphorylation progressive supranuclear palsy Protein Processing, Post-Translational Protein Processing, Post-Translational - physiology Rats Real-Time Polymerase Chain Reaction RNA, Messenger RNA, Messenger - biosynthesis RNA, Messenger - genetics Serine Serine - metabolism |
| Title | Enteric GFAP expression and phosphorylation in Parkinson's disease |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjnc.12742 https://www.ncbi.nlm.nih.gov/pubmed/24749759 https://www.proquest.com/docview/1559449632 https://www.proquest.com/docview/1560577377 https://www.proquest.com/docview/1566839201 https://hal.science/hal-04875764 |
| Volume | 130 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VXuBCoeWxpSCDEHBJlcSOvRanZcWyqqBCiEo9IEW2Y6sV4K26u4jy65lxHqK8hDhEipJJHMceez7782eAxwohAyKuPGuC9ZmQ3mcG4_pMNt4FpXXIG1rg_OZQzo_EwXF1vAHP-7UwrT7EMOBGnpHaa3JwY5c_Ojn6T0ETjdj-EleLAqJ3g3QUyWYVg1I41sxOVSixePonL_VFV06ICflrmHk5ak3dzmwLPvQf3LJNPu6vV3bffftJy_E_c3QDrnfhKJu09ecmbPi4DTuTiFD88wV7whJBNI28b8PVab853A68SGSCU8dezSZvmf_a0WkjM7FhZyeLJR7nFy3Pjp1GRour0zqzp0vWzQndgqPZy_fTedZtx5A5DPPKzCgu7DiMx8EhCsJuTVgtmlD6EkuYI8rOnfJFKJRElOI1d0bzKqhCm0o6awt-GzbjIvq7wBAmGVUEKfW4EYpzw22ugzcK03BV6UbwrC-Y2nVa5bRlxqd6wCzR1elfjeDRYHrWCnT81ghLd7hPktrzyeuaruWE2JQUX4oR7PWFX3eOvKxp1lYIbKXwHQ-H2_izaV7FRL9Ykw1iQqW4Un-1kRSL5pjMnbZiDZ9TordoVWnMdaoef85HfXA4TSe7_256D65hqqLlxe3B5up87e9jILWyD5LHfAeOjxXv |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dTxQxEJ8APuALICicgFZj1Jclu9tue014OS6eJx4XYyDhxWy63TYQtUe4OwL89Uy7HxG_YnzYZLOd3X7Odn6d6a8ArwRCBkRccVTawkSMGxMptOsjXhpthZQ2Lv0G56MxH56ww9PsdAH2m70wFT9Eu-DmNSP8r72C-wXpH7UcFSjxnsZFeOBP9A6A6nNLHuWJs5KWKxzHZs0rFOJ4mlfvzUaLZz4W8ldD877dGiaewSp8aYpcxZt83ZvPij19-xOb4__WaQ1WaouU9Koh9AgWjFuHjZ5DNP79hrwmIUY0LL6vw3K_OR9uAw5CPMG5Ju8HvU_EXNcRtY4oV5KLs8kUr8ubKtSOnDvi91eHrWZvpqR2Cz2Gk8G74_4wqk9kiDRaemmkBGVF13a7ViMQwpmNFZKVNjUpdjJFoB1rYRKbCI5AxUiqlaSZFYlUGddFkdAnsOQmzmwBQaSkRGI5l92SCUoVLWJpjRKYh85S3YG3Tc_kuqYr96dmfMtb2OJ0HtqqAy9b0YuKo-O3Qti9bbpn1R72Rrl_FnvQJji7Sjqw0_R-XuvyNPeOW8bwR4XfeNEmY2N714pyZjL3MggLhaBC_FWGe3M0xmw2q5HVFidFhZEik1jrMD7-XI_8cNwPN0__XfQ5LA-Pj0b56MP44zY8xBKwKkxuB5Zml3Ozi3bVrHgW1OcO4-YaCg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwEB71kICXtrQcCwUMQsBLqiR27Fh9WrYsSymrClGpD0iR49hqBfWuuruI9td37ByiXEI8RIriSXzNxPPZ488AzwVCBkRccVTZ0kSMGxMp9OsjXhlthZQ2rvwG5w9jPjpi-8fZ8RLstnthan6IbsLNW0b4X3sDn1b2RyNH-0n8QuMyrDIe516l9z523FGeNyvpqMJRNRtaoRDG0756bTBaPvGhkL_6mdfd1jDuDNfhc1viOtzky85iXu7oy5_IHP-zShuw1vijpF8r0G1YMm4TtvoOsfjZBXlBQoRomHrfhJuD9nS4LXgdoglONXk77B8S872Jp3VEuYpMTyYzvM4v6kA7cuqI310dNpq9nJFmUegOHA3ffBqMouY8hkijn5dGSlBW5jbPrUYYhOMaKyWrbGpS7GKKMDvWwiQ2ERxhipFUK0kzKxKpMq7LMqF3YcVNnLkPBHGSEonlXOYVE5QqWsbSGiUwD52lugev2o4pdENW7s_M-Fp0oMXpIrRVD551otOaoeO3Qti7Xbrn1B71Dwr_LPaQTXD2LenBdtv5RWPJs8Iv2zKGvyn8xtMuGRvbL6woZyYLL4OgUAgqxF9luHdGY8zmXq1YXXFSNBcpMom1Durx53oU--NBuHnw76JP4Mbh3rA4eDd-_xBuYQFYHSO3DSvz84V5hE7VvHwcjOcKmc4Ywg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Enteric+GFAP+expression+and+phosphorylation+in+Parkinson%27s+disease&rft.jtitle=Journal+of+neurochemistry&rft.au=Clairembault%2C+Thomas&rft.au=Kamphuis%2C+Willem&rft.au=Leclair-Visonneau%2C+Laur%C3%A8ne&rft.au=Rolli-Derkinderen%2C+Malvyne&rft.date=2014-09-01&rft.eissn=1471-4159&rft.volume=130&rft.issue=6&rft.spage=805&rft_id=info:doi/10.1111%2Fjnc.12742&rft_id=info%3Apmid%2F24749759&rft.externalDocID=24749759 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon |